학술논문

Durable molecular remissions in chronic lymphocytic leukemia treated with CD19-Specific chimeric antigen Receptor-modified T cells after failure of ibrutinib
Document Type
Article
Source
In: Journal of Clinical Oncology. (Journal of Clinical Oncology, 10 September 2017, 35(26):3010-3020)
Subject
Language
English
ISSN
15277755
0732183X